Phase III Data And GMP Nod Bring Prestige’s Trastuzumab Closer To Launch

Latest Developments Bode Well For Tuznue Biosimilar Rival To Herceptin

 
• By David Wallace
  
Double Six Red Dice Good Luck
Two positive developments will allow Prestige to move forward • Source: Stocksolutions / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products